STOCK TITAN

Treace Medical Concepts, Inc. (TMCI) EPS by Year

TMCI

Treace Medical Concepts, Inc. lost $0.93 per diluted share in fiscal year 2025. This represents a decrease of 3.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $0.92 per diluted share. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Treace Medical Concepts, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.93
YoY -3.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TMCI EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
EPS (Diluted)-$0.92-$0.93-3.3%-$0.90-11.1%-$0.81-5.2%-$0.77-79.1%-$0.43-$0.12N/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

TMCI EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'25DEF 14AQ3'2510-QQ2'2510-QQ1'2510-QQ4'24DEF 14AQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.24+14.3%-$0.28-12.0%-$0.14-1300.0%-$0.26-4.0%-$0.28+17.6%-$0.25+16.7%-$0.01+90.0%-$0.25+10.7%-$0.34-70.0%-$0.30-30.4%-$0.10-42.9%-$0.28-27.3%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Treace Medical Concepts, Inc. financials

Frequently Asked Questions

What was Treace Medical Concepts, Inc.'s diluted earnings per share in fiscal year 2025?

Treace Medical Concepts, Inc. lost $0.93 per diluted share in fiscal year 2025.

How fast is Treace Medical Concepts, Inc.'s diluted earnings per share growing?

Treace Medical Concepts, Inc. (TMCI) diluted earnings per share fell by 3.3% year over year, from -$0.90 to -$0.93 in fiscal year 2025.

What is Treace Medical Concepts, Inc.'s diluted earnings per share over the last twelve months?

Treace Medical Concepts, Inc. (TMCI) reported a loss of $0.92 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Treace Medical Concepts, Inc. (TMCI) reported -$0.24 in diluted earnings per share in Q2 2026. This represents an increase of 14.3% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Treace Medical Concepts, Inc. (TMCI) reported on that line in every period on record.